If recent headlines are any indication, 2025 will be a pivotal year for setting the course of private equity investment in ...

Amedisys, Inc. (NASDAQ:AMED – Free Report) – Research analysts at Leerink Partnrs cut their FY2024 earnings estimates for Amedisys in a note issued to investors on Wednesday, January 29th.

In a report released on January 29, Whit Mayo from Leerink Partners reiterated a Hold rating on Amedisys (AMED – Research Report), with a price target of $101.00. Whit Mayo has given his Hold ...

BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the ...

After hours: February 4 at 4:20:00 PM EST Loading Chart for AMED ...

GRDN Guardian Pharmacy Services, Inc.

DiveWire guarantees visibility for your news announcements through instant distribution to Healthcare Dive’s audience and its 141,500 newsletter subscribers for 21 days.